Investigation of Biofield Treatment on Antimicrobial Susceptibility, Biochemical Reaction Pattern and Biotyping of Enteropathogenic Multidrug-Resistant Escherichia coli Isolates

Article English OPEN
Trivedi, Mahendra Kumar; Branton, Alice; Trivedi, Dahryn; Nayak, Gopal; Shettigar, Harish; Gangwar, Mayank; Jana, Snehasis;
(2015)
  • Publisher: Omics Publishing Group
  • Related identifiers: doi: 10.4172/2327-5146.1000S2-002, doi: 10.5281/zenodo.167911, doi: 10.5281/zenodo.167756
  • Subject: Escherichia coli | Biofield treatment | Mahendra Trivedi | Antimicrobial susceptibility | Biochemical reaction | Escherichia Coli Biochemical Characteristics | Trivedi Effect | Biotyping | Multidrug-resistant | Escherichia Coli Biochemical Tests | [ SDV.MP ] Life Sciences [q-bio]/Microbiology and Parasitology

Study background: Multidrug resistant Escherichia coli (MDR E. coli) has become a major health concern, and failure of treatment leads to huge health burden. Aim of the present study was to determine the impact of Mr. Trivedi’s biofield treatment on E. coli. Methods... View more
  • References (34)
    34 references, page 1 of 4

    1. Bélanger L, Garenaux A, Harel J, Boulianne M, Nadeau E, et al. (2011) Escherichia coli from animal reservoirs as a potential source of human extraintestinal pathogenic E. coli. FEMS Immunol Med Microbiol 62: 1-10.

    2. Kaper JB, Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2: 123-140.

    3. Russo TA, Johnson JR (2003) Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect 5: 449-456.

    4. Furyk JS, Swann O, Molyneux E (2011) Systematic review: neonatal meningitis in the developing world. Trop Med Int Health 16: 672-679.

    5. Bonacorsi S, Bingen E (2005) Molecular epidemiology of Escherichia coli causing neonatal meningitis. Int J Med Microbiol 295: 373-381.

    6. Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA (2001) Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother 45: 1402-1406.

    7. Coates A, Hu Y, Bax R, Page C (2002) The future challenges facing the development of new antimicrobial drugs. Nat Rev Drug Discov 1: 895-910.

    8. Bartoloni A, Pallecchi L, Benedetti M, Fernandez C, Vallejos Y, et al. (2006) Multidrug-resistant commensal Escherichia coli in children, Peru and Bolivia. Emerg Infect Dis 12: 907-913.

    9. Lucchetti G, de Oliveira RF, Gonçalves JP, Ueda SM, Mimica LM, et al. (2013) Efect of Spiritist "passe" (Spiritual healing) on growth of bacterial cultures. Complement Ther Med 21: 627-632.

    10. Trivedi MK, Patil S, Shettigar H, Gangwar M, Jana S (2015) Antimicrobial sensitivity pattern of Pseudomonas fluorescens after biofield treatment. J Infect Dis Ther 3: 222.

  • Similar Research Results (1)
  • Metrics
Share - Bookmark